Figure 1From: The original sins of clinical trials with intravenous immunoglobulins in sepsis Potential confounding factors not appropriately considered in the design or analysis of the clinical trials evaluating IVIG for the treatment of sepsis. Main factors are in bold. Other factors related to them are in standard type. IVIG, intravenous immunoglobulin; NK, natural killer.Back to article page